Coronary artery disease in south Asians: Evolving strategies for treatment and prevention

Indian Heart Journal

Volumn 57, Issue 6, 2005, Pages 617-631

  Deedwania, Prakash ^a,b   Singh, Vibhuti ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANTIOXIDANT; ATORVASTATIN; BEZAFIBRATE; BILE ACID SEQUESTRANT; CHOLESTEROL ESTER TRANSFER PROTEIN; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; ETC 216; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FISH OIL; FOLIC ACID; GEMFIBROZIL; GLIMEPIRIDE; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; METFORMIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PIOGLITAZONE; PYRIDOXINE; RAMIPRIL; ROSUVASTATIN; SIMVASTATIN; TORCETRAPIB; UNINDEXED DRUG;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE HEART INFARCTION; ADDICTION; AMINO ACID BLOOD LEVEL; ASIAN; CALORIC INTAKE; CANCER; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; DENTAL CARIES; DIABETES MELLITUS; DRUG SAFETY; DYSLIPIDEMIA; ESTROGEN THERAPY; FAT INTAKE; FLUSHING; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID DIET; LIVER TOXICITY; METABOLIC SYNDROME X; MYALGIA; MYOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PROTEIN INTAKE; REVIEW; RHABDOMYOLYSIS; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VEGETARIAN; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL; CORONARY DISEASE; DIET; EXERCISE; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; PREVALENCE; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33644691784     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. American Heart Association. Heart disease and stroke statistics 2005 update (http://www.americanheart.org/downloadable/heart/ 1105390918119HDSStats2005Update.pdf)
2. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 1995; 345: 405-409
3. Bhopal R, Hayes L, White M, Unwin N, Harland J, Ayis S, et al. Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med 2002; 24: 95-105
4. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol 1989; 42: 597-609
5. Anand SS, Yusuf S, Vuksan V, Devanesen S, Montague P, Kelemen L, et al. The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. Can J Cardiol 1998; 14: 1349-1357
6. Mathur KS. Environmental factors in coronary heart disease. An epidemiological study at Agra (India). Circulation 1960; 21: 684-689
7. Padmavati S. Epidemiology of cardiovascular disease in India. II. Ischemic heart diasease. Circulation 1962; 25: 711-717
8. Sarvotham SG, Berry JN. Prevalence of coronary heart disease in an urban population in Northern India. Circulation 1968; 37: 939-953
9. Gupta SP, Malhotra KC. Urban-rural trends in epidemiology of coronary heart disease. J Assoc Physicians India 1975; 23: 885-892
10. Jajoo UN, Kalantri SP, Gupta OP, Jain AP, Gupta K. The prevalence of coronary heart disease in rural population from central India. J Assoc Physicians India 1988; 36: 689-693
11. Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N. Epidemiological study of coronary heart disease in urban population of Delhi. Indian J Med Res 1990; 92: 424-430
12. Kutty VR, Balakrishnan KG, Jayasree AK, Thomas J. Prevalence of coronary heart disease in the rural population of Thiruvananthapuram district, Kerala, India. Int J Cardiol 1993; 39: 59-70
13. Wander GS, Khurana SB, Gulati R, Sachar RK, Gupta RK, Khurana S, et al. Epidemiology of coronary heart disease in a rural Punjab population - prevalence and correlation with various risk factors. Indian Heart J 1994; 46: 319-323
14. Gupta R, Gupta VP, Ahluwalia NS. Educational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India. BMJ 1994; 309: 1332-1336
15. Gupta R, Prakash H, Majumdar S, Sharma S, Gupta VP. Prevalence of coronary heart disease and coronary risk factors in an urban population of Rajasthan. Indian Heart J 1995; 47: 331-338
16. Dewan BD, Malhotra KC, Gupta SP. Epidemiological study of coronary heart disease in rural community of Haryana. Indian Heart J 1974; 26: 68-78
17. Begom R, Singh RB. Prevalence of coronary artery disease and its risk factors in the urban population of South and North India. Acta Cardiol 1995; 50: 227-240
18. Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001; 38: 682-687
19. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004; 97: 257-261
20. Enas EA, Yusuf S, Mehta J. Meeting of the International Working Group on Coronary Artery Disease in South Asians. Indian Heart J 1996; 48: 727-732
21. Singh RB, Niaz MA. Coronary risk factors in Indians. Lancet 1995; 346: 778-779
22. Shaukat N, de Bono DP, Jones DR. Like father like son? Sons of patients of European or Indian origin with coronary artery disease reflect their parents' risk factor patterns. Br Heart J 1995; 74: 318-323
23. Gupta R, Gupta VP. Meta-analysis of coronary heart disease prevalence in India. Indian Heart J 1996; 48: 241-245
24. Kraus JF, Borhani NO, Franti CE. Socioeconomic status, ethnicity, and risk of coronary heart disease. Am J Epidemiol 1980; 111: 407-414.
25. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001; 25: 1722-1729
26. Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP. Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol 1999; 19: 2749-2755
27. Varghese PJ, Arumugam SB, Cherian KM, Walley V, Farb A, Virmani R. Atheromatous plaque reflects serum total cholesterol levels: a comparative morphologic study of endarterectomy coronary atherosclerotic plaques removed from patients from the southern part of India and Caucasians from Ottawa, Canada. Clin Cardiol 1998; 21: 335-340
28. Lee J, Heng D, Chia KS, Chew SK, Tan BY, Hughes K. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int J Epidemiol 2001; 30: 983-988
29. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA. Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med 1993; 329: 73-78
30. Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, et al. Evaluation of Lp(a) and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001; 42: 631-638
31. Ramachandran A, Snehalatha C, Latha E, Satyavani K, Vijay V. Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care 1998; 21: 967-971
32. Deedwania PC. Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease? Circulation 2004; 109: 2-4
33. Deedwania PC, Volkova N. Current treatment options for the metabolic syndrome. Curr Treat Options Cardiovasc Med 2005; 7: 61-74
34. Giles TD, Sanders GE. Pathophysiologic, diagnostic and therapeutic aspects of metabolic syndrome. J Clin Hypertens 2005; 7: 669-678
35. Wagh A, Stone NJ. Treatment of metabolic syndrome. Expert Rev Cardiovasc Ther 2004; 2: 213-228
36. Fruchart JC. Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism. Am J Cardiol 2001; 88: 24N-29N
37. Deepa R, Velmurugan K, Saravanan G, Dwarakanath V, Agarwal S, Mohan V. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects. J Assoc Physicians India 2002; 50: 901-906
38. Ramachandran A, Sathyamurthy I, Snehalatha C, Satyavani K, Sivasankari S, Misra J, et al. Risk variables for coronary artery disease in Asian Indians. Am J Cardiol 2001; 87: 267-271
39. Chadha SL, Gopinath N, Katyal I, Shekhawat S. Dietary profile of adults in an urban and a rural community. Indian J Med Res 1995; 101; 258-267
40. Pais P, Pogue J, Gerstein H, Zachariah E, Savitha D, Jayprakash S, et al. Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet 1996; 348: 358-363
41. Reddy KS, Shah P, Shrivastava U, Prabhakaran D, Joshi M, Puri SK, et al. Coronary heart disease risk factors in an industrial population of north India. Can J Cardiol 1997; 13: 3
42. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596-601
43. Chandalia M, Deedwania PC. Coronary heart disease and risk factors in Asian Indians. Adv Exp Med Biol 2001; 498: 27-34
44. WHO. The Global Burden of Disease and Global Health Statistics. Harvard University Press, 1990
45. Misra A, Luthra K, Vikram NK. Dyslipidemia in Asian Indians: determinants and significance. J Assoc Physicians India 2004; 52: 137-142
46. Kumar P, Luthra K, Dwivedi M, Behl VK, Pandey RM, Misra A. Apolipoprotein E gene polymorphisms in patients with premature myocardial infarction: a case-controlled study in Asian Indians in North India. Ann Clin Biochem 2003; 40: 382-387
47. Tan JH, Low PS, Tan YS, Tong MC, Saha N, Yang H, Heng CK. ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore. Hum Genet 2003; 113: 106-117
48. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952
49. Pollard TM, Carlin LE, Bhopal R, Unwin N, White M, Fischbacher C. Social networks and coronary heart disease risk factors in South Asians and Europeans in the UK. Ethn Health 2003; 8: 263-275
50. Chambers JC, Obeid OA, Refsum H, Ueland P, Hackett D, Hooper J, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000; 355: 523-527
51. Deepa R, Velmurugan K, Saravanan G, Karkuzhali K, Dwarakanath V, Mohan V. Absence of association between serum homocysteine levels and coronary artery disease in south Indian males. Indian Heart J 2001: 53: 44-47
52. Chacko KA. Plasma homocysteine levels in patients with coronary heart disease. Indian Heart J 1998; 50: 295-299
53. Snehalatha C, Ramachandran A, Satyavani K, Sivasankari S, Sathyamurthy I, Viswanathan V. Plasma homocysteine concentration and coronary artery disease in Asian Indians. J Assoc Physicians India 2002; 50: 1229-1231
54. Ranjith N, Pegoraro RJ, Rom L, Rajput MC, Naidoo DP. Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction. Cardiovasc J S Afr 2004; 15: 111-117
55. Makaryus AN, Dhama B, Raince J, Raince A, Garyali S, Labana SS, et al. Coronary artery diameter as a risk factor for acute coronary syndromes in Asian-Indians. Am J Cardiol 2005; 96: 778-780
56. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, Mc Cartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347: 1483-1492
57. Bhalodkar NC, Blum S, Rana T, Bhalodkar A, Kitchappa R, Enas EA. Effect of leisure time exercise on high-density lipoprotein cholesterol, its sub-classes, and size in Asian Indians. Am J Cardiol 2005; 96: 98-100
58. Singh VN. New ATP III Lipid Guidelines Update for Patients at High Risk for Cardiovascular Events. eMEDICINE Feature Series - LIPID Newsletter. July 21, 2005. Available at: http:/reports.emedicine.com:1099/crestor9.htm
59. Singh VN. Need for More Aggressive Statin Use in Various Ethnic Groups - Latinos, Asians, and African-Americans. eMEDICINE Feature Series- LIPID Newsletter. October 20, 2005. Available at: http://reports.emedicine.com:1099/ crestor12.htm.
60. Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, et al. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Indian Heart J 2003; 55: 234-240
61. Miller GJ, Beckles GL, Alexis SD, Byam NT, Price SG. Serum lipoproteins and susceptibility of men of Indian descent to coronary heart disease. The St James Survey, Trinidad. Lancet 1982; 2: 200-203
62. Singh VN. The USDA. "Food Pyramid" Needs To Go On Diet. Guest Editorial, Pinellas County Medical Society (PICOMESO) Journal. PICOMESO 2004; 43: 18-19
63. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239
64. Tan CE, Loh LM, Tai ES. Do Singapore patients require lower doses of statins? The SGH Lipid Clinic experience. Singapore Med J 2003; 44: 635-638
65. Ramachandran A, Snehalatha C, Salini J, Vijay V. Use of glimepiride and insulin sensitizers in the treatment of type 2 diabetes - a study in Indians. J Assoc Physicians India 2004; 52: 459-463
66. Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 160-167
67. de Grooth GJ, Kuivenhoven JA, Stalenhoef AF, de Graaf J, Zwinderman AH, Posma JL, et al. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation 2002; 105: 2159-2165
68. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290: 2292-2300
69. Zema MJ. Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study. J Am Coll Cardiol 2000; 35: 640-646
70. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583-1592
71. Taylor AJ, Sullenberger LE, Lee HJ, Grace KA. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extendedrelease niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004; 110: 3512-3517
72. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319: 1523-1528
73. Kris-Etherton PM, Harris WS, Appel LJ. American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757
74. Ghafoorunissa, Vani A, Laxmi R, Sesikeran B. Effects of dietary alpha-linolenic acid from blended oils on biochemical indices of coronary heart disease in Indians. Lipids 2002; 37: 1077-1086
75. Lonn E. Do antioxidant vitamins protect against atherosclerosis? The proof is still lacking. J Am Coll Cardiol 2001; 38: 1795-1798
76. Venkataraman R, Nanda NC, Baweja G, Parikh N, Bhatia V. Prevalence of diabetes mellitus and related conditions in Asian Indians living in the United States. Am J Cardiol 2004; 94: 977-980
77. Ghosh A. Factor analysis of metabolic syndrome among the middle-aged Bengalee Hindu men of Calcutta, India. Diabetes Metab Res Rev 2005; 21: 58-64
78. Misra A, Vikram NK, Arya S, Pandey RM, Dhingra V, Chatterjee A, et al. High prevalence of insulin resistance in postpubertal Asian Indian children is associated with adverse truncal body fat patterning, abdominal adiposity and excess body fat. Int J Obes Relat Metab Disord 2004; 28: 1217-1226
79. Palaniappan L, Wang Y, Fortmann SP. Coronary heart disease mortality for six ethnic groups in California, 1990-2000. Ann Epidemiol 2004; 14: 499-506
80. Tai ES, Tan CE. Genes, diet and serum lipid concentrations: lessons from ethnically diverse populations and their relevance to coronary heart disease in Asia. Curr Opin Lipidol 2004; 15: 5-12
81. Bajaj M, Banerji MA. Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic. Curr Diab Rep 2004; 4: 213-218
82. Singh VN, Deedwania PC. Dyslipidemia in special populations: Asian Indians, African Americans and Hispanics. Current Atherosclerosis Reports 2006 (in press)
83. Kennedy J, Mogensen CE, Ball SG, Castaigne AD, Coommerford PJ, Distiller L, et al. What is the relevance of the HOPE study in general practice? Int J Clin Pract 2001; 55: 449-457
84. Leenen R, van der Kooy K, Meyboom S, Seidell JC, Deurenberg P, Weststrate JA. Relative effects of weight loss and dietary fat modification on serum lipid levels in the dietary treatment of obesity. J Lipid Res 1993; 34: 2183-2191
85. Singh VN, Deedwania PC, Sharma RK. Coronary artery atherosclerosis-2005 Update. In eMedicine Specialties-Medicine, Ob/Gyn, Psychiatry and Surgery- Cardiology (Stouffer GA, Talavera F, Runge MS, Suleman A, and Zevitz M, ed). eMedicine 2005; Available at: http://www.emedicine.com/med/topic446.htm.
86. Manav M, Su J, Hughes K, Lee HP, Ong CN. Omega-3 fatty acids and selenium as coronary heart disease risk modifying factors in Asian Indian and Chinese males. Nutrition 2004; 20: 967-973